These terms and conditions govern your use of the website alphaminr.com and its related services.
These Terms and Conditions (“Terms”) are a binding contract between you and Alphaminr, (“Alphaminr”, “we”, “us” and “service”). You must agree to and accept the Terms. These Terms include the provisions in this document as well as those in the Privacy Policy. These terms may be modified at any time.
Your subscription will be on a month to month basis and automatically renew every month. You may terminate your subscription at any time through your account.
We will provide you with advance notice of any change in fees.
You represent that you are of legal age to form a binding contract. You are responsible for any
activity associated with your account. The account can be logged in at only one computer at a
time.
The Services are intended for your own individual use. You shall only use the Services in a
manner that complies with all laws. You may not use any automated software, spider or system to
scrape data from Alphaminr.
Alphaminr is not a financial advisor and does not provide financial advice of any kind. The service is provided “As is”. The materials and information accessible through the Service are solely for informational purposes. While we strive to provide good information and data, we make no guarantee or warranty as to its accuracy.
TO THE EXTENT PERMITTED BY APPLICABLE LAW, UNDER NO CIRCUMSTANCES SHALL ALPHAMINR BE LIABLE TO YOU FOR DAMAGES OF ANY KIND, INCLUDING DAMAGES FOR INVESTMENT LOSSES, LOSS OF DATA, OR ACCURACY OF DATA, OR FOR ANY AMOUNT, IN THE AGGREGATE, IN EXCESS OF THE GREATER OF (1) FIFTY DOLLARS OR (2) THE AMOUNTS PAID BY YOU TO ALPHAMINR IN THE SIX MONTH PERIOD PRECEDING THIS APPLICABLE CLAIM. SOME STATES DO NOT ALLOW THE EXCLUSION OR LIMITATION OF INCIDENTAL OR CONSEQUENTIAL OR CERTAIN OTHER DAMAGES, SO THE ABOVE LIMITATION AND EXCLUSIONS MAY NOT APPLY TO YOU.
If any provision of these Terms is found to be invalid under any applicable law, such provision shall not affect the validity or enforceability of the remaining provisions herein.
This privacy policy describes how we (“Alphaminr”) collect, use, share and protect your personal information when we provide our service (“Service”). This Privacy Policy explains how information is collected about you either directly or indirectly. By using our service, you acknowledge the terms of this Privacy Notice. If you do not agree to the terms of this Privacy Policy, please do not use our Service. You should contact us if you have questions about it. We may modify this Privacy Policy periodically.
When you register for our Service, we collect information from you such as your name, email address and credit card information.
Like many other websites we use “cookies”, which are small text files that are stored on your computer or other device that record your preferences and actions, including how you use the website. You can set your browser or device to refuse all cookies or to alert you when a cookie is being sent. If you delete your cookies, if you opt-out from cookies, some Services may not function properly. We collect information when you use our Service. This includes which pages you visit.
We use Google Analytics and we use Stripe for payment processing. We will not share the information we collect with third parties for promotional purposes. We may share personal information with law enforcement as required or permitted by law.
FORM 10-Q
|
x
|
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
|
o
|
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934
|
|
|
Ohio
|
|
31-0411980
|
(State of Incorporation)
|
|
(I.R.S. Employer Identification Number)
|
One Procter & Gamble Plaza, Cincinnati, Ohio
|
|
45202
|
(Address of principal executive offices)
|
|
(Zip Code)
|
|
|
Three Months Ended March 31
|
|
Nine Months Ended March 31
|
||||||||||||
Amounts in millions except per share amounts
|
2013
|
|
2012
|
|
2013
|
|
2012
|
||||||||
Net Sales
|
$
|
20,598
|
|
|
$
|
20,194
|
|
|
$
|
63,512
|
|
|
$
|
63,468
|
|
Cost of products sold
|
10,344
|
|
|
10,237
|
|
|
31,574
|
|
|
31,894
|
|
||||
Selling, general and administrative expense
|
6,849
|
|
|
6,636
|
|
|
20,090
|
|
|
19,769
|
|
||||
Goodwill and Intangibles impairment charges
|
—
|
|
|
22
|
|
|
—
|
|
|
1,576
|
|
||||
Operating Income
|
3,405
|
|
|
3,299
|
|
|
11,848
|
|
|
10,229
|
|
||||
Interest expense
|
163
|
|
|
179
|
|
|
504
|
|
|
587
|
|
||||
Other non-operating income
|
46
|
|
|
67
|
|
|
988
|
|
|
238
|
|
||||
Earnings From Continuing Operations Before Income Taxes
|
3,288
|
|
|
3,187
|
|
|
12,332
|
|
|
9,880
|
|
||||
Income taxes on continuing operations
|
697
|
|
|
754
|
|
|
2,812
|
|
|
2,776
|
|
||||
Net Earnings from Continuing Operations
|
2,591
|
|
|
2,433
|
|
|
9,520
|
|
|
7,104
|
|
||||
Net Earnings from Discontinued Operations
|
—
|
|
|
34
|
|
|
—
|
|
|
133
|
|
||||
Net Earnings
|
2,591
|
|
|
2,467
|
|
|
9,520
|
|
|
7,237
|
|
||||
Less: Net earnings attributable to noncontrolling interests
|
25
|
|
|
56
|
|
|
83
|
|
|
112
|
|
||||
Net Earnings Attributable to Procter & Gamble
|
$
|
2,566
|
|
|
$
|
2,411
|
|
|
$
|
9,437
|
|
|
$
|
7,125
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
Basic Net Earnings per Common Share
(1)
|
|
|
|
|
|
|
|
||||||||
Earnings from continuing operations
|
$
|
0.92
|
|
|
$
|
0.84
|
|
|
$
|
3.38
|
|
|
$
|
2.47
|
|
Earnings from discontinued operations
|
—
|
|
|
0.01
|
|
|
—
|
|
|
0.05
|
|
||||
Basic Net Earnings per Common Share
|
0.92
|
|
|
0.85
|
|
|
3.38
|
|
|
2.52
|
|
||||
Diluted Net Earnings per Common Share
(1)
|
|
|
|
|
|
|
|
||||||||
Earnings from continuing operations
|
0.88
|
|
|
0.81
|
|
|
3.22
|
|
|
2.37
|
|
||||
Earnings from discontinued operations
|
—
|
|
|
0.01
|
|
|
—
|
|
|
0.05
|
|
||||
Diluted Net Earnings per Common Share
|
0.88
|
|
|
0.82
|
|
|
3.22
|
|
|
2.42
|
|
||||
Dividends
|
$
|
0.562
|
|
|
$
|
0.525
|
|
|
$
|
1.686
|
|
|
$
|
1.575
|
|
Diluted Weighted Average Common Shares Outstanding
|
2,930.7
|
|
|
2,937.8
|
|
|
2,927.6
|
|
|
2,944.9
|
|
|
|
Three Months Ended March 31
|
|
Nine Months Ended March 31
|
||||||||||||
Amounts in millions
|
|
2013
|
|
2012
|
|
2013
|
|
2012
|
||||||||
NET EARNINGS
|
|
$
|
2,591
|
|
|
$
|
2,467
|
|
|
$
|
9,520
|
|
|
$
|
7,237
|
|
OTHER COMPREHENSIVE INCOME (LOSS), NET OF TAX
|
|
|
|
|
|
|
|
|
||||||||
Financial statement translation
|
|
(1,143
|
)
|
|
1,378
|
|
|
604
|
|
|
(3,694
|
)
|
||||
Hedges
|
|
358
|
|
|
(60
|
)
|
|
212
|
|
|
502
|
|
||||
Investment securities
|
|
8
|
|
|
3
|
|
|
9
|
|
|
(3
|
)
|
||||
Defined benefit retirement plans
|
|
189
|
|
|
(10
|
)
|
|
226
|
|
|
186
|
|
||||
TOTAL OTHER COMPREHENSIVE INCOME (LOSS), NET OF TAX
|
|
(588
|
)
|
|
1,311
|
|
|
1,051
|
|
|
(3,009
|
)
|
||||
TOTAL COMPREHENSIVE INCOME
|
|
2,003
|
|
|
3,778
|
|
|
10,571
|
|
|
4,228
|
|
||||
LESS TOTAL COMPREHENSIVE INCOME ATTRIBUTABLE TO NONCONTROLLING INTERESTS
|
|
18
|
|
|
60
|
|
|
87
|
|
|
107
|
|
||||
TOTAL COMPREHENSIVE INCOME ATTRIBUTABLE TO PROCTER & GAMBLE
|
|
$
|
1,985
|
|
|
$
|
3,718
|
|
|
$
|
10,484
|
|
|
$
|
4,121
|
|
|
|
|
|
|
|
|
|
||||
Amounts in millions
|
|
|
|
|
March 31, 2013
|
|
June 30, 2012
|
||||
ASSETS
|
|
|
|
|
|
|
|
||||
CURRENT ASSETS
|
|
|
|
|
|
|
|
||||
Cash and cash equivalents
|
|
|
|
|
$
|
5,876
|
|
|
$
|
4,436
|
|
Accounts receivable
|
|
|
|
|
6,669
|
|
|
6,068
|
|
||
Inventories
|
|
|
|
|
|
|
|
||||
Materials and supplies
|
|
|
|
|
1,777
|
|
|
1,740
|
|
||
Work in process
|
|
|
|
|
721
|
|
|
685
|
|
||
Finished goods
|
|
|
|
|
4,742
|
|
|
4,296
|
|
||
Total inventories
|
|
|
|
|
7,240
|
|
|
6,721
|
|
||
Deferred income taxes
|
|
|
|
|
937
|
|
|
1,001
|
|
||
Prepaid expenses and other current assets
|
|
|
|
|
3,576
|
|
|
3,684
|
|
||
TOTAL CURRENT ASSETS
|
|
|
|
|
24,298
|
|
|
21,910
|
|
||
PROPERTY, PLANT AND EQUIPMENT
|
|
|
|
|
|
|
|
||||
Buildings
|
|
|
|
|
7,661
|
|
|
7,324
|
|
||
Machinery and equipment
|
|
|
|
|
33,810
|
|
|
32,029
|
|
||
Land
|
|
|
|
|
878
|
|
|
880
|
|
||
Total property, plant and equipment
|
|
|
|
|
42,349
|
|
|
40,233
|
|
||
Accumulated depreciation
|
|
|
|
|
(21,158
|
)
|
|
(19,856
|
)
|
||
NET PROPERTY, PLANT AND EQUIPMENT
|
|
|
|
|
21,191
|
|
|
20,377
|
|
||
GOODWILL AND OTHER INTANGIBLE ASSETS
|
|
|
|
|
|
|
|
||||
Goodwill
|
|
|
|
|
55,067
|
|
|
53,773
|
|
||
Trademarks and other intangible assets, net
|
|
|
|
|
31,739
|
|
|
30,988
|
|
||
NET GOODWILL AND OTHER INTANGIBLE ASSETS
|
|
|
|
|
86,806
|
|
|
84,761
|
|
||
OTHER NONCURRENT ASSETS
|
|
|
|
|
6,836
|
|
|
5,196
|
|
||
TOTAL ASSETS
|
|
|
|
|
$
|
139,131
|
|
|
$
|
132,244
|
|
|
|
|
|
|
|
|
|
|
|
||
LIABILITIES AND SHAREHOLDERS’ EQUITY
|
|
|
|
|
|
|
|
||||
CURRENT LIABILITIES
|
|
|
|
|
|
|
|
||||
Accounts payable
|
|
|
|
|
$
|
7,422
|
|
|
$
|
7,920
|
|
Accrued and other liabilities
|
|
|
|
|
8,892
|
|
|
8,289
|
|
||
Debt due within one year
|
|
|
|
|
11,098
|
|
|
8,698
|
|
||
TOTAL CURRENT LIABILITIES
|
|
|
|
|
27,412
|
|
|
24,907
|
|
||
LONG-TERM DEBT
|
|
|
|
|
21,125
|
|
|
21,080
|
|
||
DEFERRED INCOME TAXES
|
|
|
|
|
10,725
|
|
|
10,132
|
|
||
OTHER NONCURRENT LIABILITIES
|
|
|
|
|
11,916
|
|
|
12,090
|
|
||
TOTAL LIABILITIES
|
|
|
|
|
71,178
|
|
|
68,209
|
|
||
SHAREHOLDERS’ EQUITY
|
|
|
|
|
|
|
|
||||
Preferred stock
|
|
|
|
|
1,143
|
|
|
1,195
|
|
||
Common stock – shares issued –
|
March 2013
|
|
4,009.0
|
|
|
|
|
||||
|
June 2012
|
|
4,008.4
|
|
4,009
|
|
|
4,008
|
|
||
Additional paid-in capital
|
|
|
|
|
63,358
|
|
|
63,181
|
|
||
Reserve for ESOP debt retirement
|
|
|
|
|
(1,351
|
)
|
|
(1,357
|
)
|
||
Accumulated other comprehensive income (loss)
|
|
|
|
|
(8,282
|
)
|
|
(9,333
|
)
|
||
Treasury stock
|
|
|
|
|
(71,644
|
)
|
|
(69,604
|
)
|
||
Retained earnings
|
|
|
|
|
80,035
|
|
|
75,349
|
|
||
Noncontrolling interest
|
|
|
|
|
685
|
|
|
596
|
|
||
TOTAL SHAREHOLDERS’ EQUITY
|
|
|
|
|
67,953
|
|
|
64,035
|
|
||
TOTAL LIABILITIES AND SHAREHOLDERS’ EQUITY
|
|
|
|
|
$
|
139,131
|
|
|
$
|
132,244
|
|
|
Nine Months Ended March 31
|
||||||
Amounts in millions
|
2013
|
|
2012
|
||||
CASH AND CASH EQUIVALENTS, BEGINNING OF PERIOD
|
$
|
4,436
|
|
|
$
|
2,768
|
|
OPERATING ACTIVITIES
|
|
|
|
||||
Net earnings
|
9,520
|
|
|
7,237
|
|
||
Depreciation and amortization
|
2,188
|
|
|
2,427
|
|
||
Share-based compensation expense
|
250
|
|
|
277
|
|
||
Deferred income taxes
|
75
|
|
|
(5
|
)
|
||
Gain on purchase/sale of businesses
|
(906
|
)
|
|
(201
|
)
|
||
Goodwill and indefinite lived intangibles impairment charges
|
—
|
|
|
1,576
|
|
||
Changes in:
|
|
|
|
||||
Accounts receivable
|
(504
|
)
|
|
(347
|
)
|
||
Inventories
|
(492
|
)
|
|
(287
|
)
|
||
Accounts payable, accrued and other liabilities
|
(84
|
)
|
|
(1,558
|
)
|
||
Other operating assets and liabilities
|
483
|
|
|
131
|
|
||
Other
|
(49
|
)
|
|
61
|
|
||
TOTAL OPERATING ACTIVITIES
|
10,481
|
|
|
9,311
|
|
||
INVESTING ACTIVITIES
|
|
|
|
||||
Capital expenditures
|
(2,426
|
)
|
|
(2,663
|
)
|
||
Proceeds from asset sales
|
559
|
|
|
290
|
|
||
Acquisitions, net of cash acquired
|
(1,148
|
)
|
|
(4
|
)
|
||
Purchases of available-for-sale investment securities
|
(1,504
|
)
|
|
—
|
|
||
Change in other investments
|
(156
|
)
|
|
90
|
|
||
TOTAL INVESTING ACTIVITIES
|
(4,675
|
)
|
|
(2,287
|
)
|
||
FINANCING ACTIVITIES
|
|
|
|
||||
Dividends to shareholders
|
(4,797
|
)
|
|
(4,521
|
)
|
||
Change in short-term debt
|
4,152
|
|
|
(122
|
)
|
||
Additions to long-term debt
|
2,253
|
|
|
3,985
|
|
||
Reductions of long-term debt
|
(3,749
|
)
|
|
(2,514
|
)
|
||
Treasury stock purchases
|
(4,985
|
)
|
|
(4,023
|
)
|
||
Impact of stock options and other
|
2,730
|
|
|
1,439
|
|
||
TOTAL FINANCING ACTIVITIES
|
(4,396
|
)
|
|
(5,756
|
)
|
||
EFFECT OF EXCHANGE RATE CHANGES ON CASH AND CASH EQUIVALENTS
|
30
|
|
|
(45
|
)
|
||
CHANGE IN CASH AND CASH EQUIVALENTS
|
1,440
|
|
|
1,223
|
|
||
CASH AND CASH EQUIVALENTS, END OF PERIOD
|
$
|
5,876
|
|
|
$
|
3,991
|
|
|
|
|
Three Months Ended March 31
|
|
Nine Months Ended March 31
|
||||||||||||||||||||
Amounts in millions
|
|
|
Net Sales
|
|
Earnings from Continuing Operations Before Income Taxes
|
|
Net Earnings from Continuing Operations
|
|
Net Sales
|
|
Earnings from Continuing Operations Before Income Taxes
|
|
Net Earnings from Continuing Operations
|
||||||||||||
Beauty
|
2013
|
|
$
|
4,763
|
|
|
$
|
692
|
|
|
$
|
535
|
|
|
$
|
15,106
|
|
|
$
|
2,682
|
|
|
$
|
2,070
|
|
|
2012
|
|
4,844
|
|
|
710
|
|
|
523
|
|
|
15,512
|
|
|
2,652
|
|
|
2,008
|
|
||||||
Grooming
|
2013
|
|
1,931
|
|
|
593
|
|
|
444
|
|
|
6,057
|
|
|
1,922
|
|
|
1,428
|
|
||||||
|
2012
|
|
1,962
|
|
|
530
|
|
|
398
|
|
|
6,332
|
|
|
1,861
|
|
|
1,401
|
|
||||||
Health Care
|
2013
|
|
3,274
|
|
|
731
|
|
|
493
|
|
|
9,714
|
|
|
2,222
|
|
|
1,512
|
|
||||||
|
2012
|
|
3,018
|
|
|
638
|
|
|
411
|
|
|
9,492
|
|
|
2,222
|
|
|
1,490
|
|
||||||
Fabric Care and Home Care
|
2013
|
|
6,587
|
|
|
1,087
|
|
|
693
|
|
|
20,711
|
|
|
3,836
|
|
|
2,502
|
|
||||||
|
2012
|
|
6,595
|
|
|
1,161
|
|
|
716
|
|
|
20,703
|
|
|
3,643
|
|
|
2,280
|
|
||||||
Baby Care and Family Care
|
2013
|
|
4,277
|
|
|
939
|
|
|
608
|
|
|
12,598
|
|
|
2,693
|
|
|
1,731
|
|
||||||
|
2012
|
|
4,153
|
|
|
903
|
|
|
573
|
|
|
12,394
|
|
|
2,511
|
|
|
1,583
|
|
||||||
Corporate
|
2013
|
|
(234
|
)
|
|
(754
|
)
|
|
(182
|
)
|
|
(674
|
)
|
|
(1,023
|
)
|
|
277
|
|
||||||
|
2012
|
|
(378
|
)
|
|
(755
|
)
|
|
(188
|
)
|
|
(965
|
)
|
|
(3,009
|
)
|
|
(1,658
|
)
|
||||||
Total
|
2013
|
|
$
|
20,598
|
|
|
$
|
3,288
|
|
|
$
|
2,591
|
|
|
$
|
63,512
|
|
|
$
|
12,332
|
|
|
$
|
9,520
|
|
|
2012
|
|
20,194
|
|
|
3,187
|
|
|
2,433
|
|
|
63,468
|
|
|
9,880
|
|
|
7,104
|
|
|
Beauty
|
Grooming
|
Health Care
|
Fabric Care and Home Care
|
Baby Care and Family Care
|
Corporate
|
Total Company
|
||||||||||||||
GOODWILL at June 30, 2012
|
$
|
16,429
|
|
$
|
20,680
|
|
$
|
8,339
|
|
$
|
6,557
|
|
$
|
1,459
|
|
$
|
309
|
|
$
|
53,773
|
|
Acquisitions and divestitures
|
(29
|
)
|
(38
|
)
|
638
|
|
(10
|
)
|
460
|
|
—
|
|
1,021
|
|
|||||||
Translation and other
|
101
|
|
100
|
|
35
|
|
19
|
|
18
|
|
—
|
|
273
|
|
|||||||
GOODWILL at March 31, 2013
|
$
|
16,501
|
|
$
|
20,742
|
|
$
|
9,012
|
|
$
|
6,566
|
|
$
|
1,937
|
|
$
|
309
|
|
$
|
55,067
|
|
|
Gross Carrying Amount
|
|
Accumulated Amortization
|
||||
Amortizable intangible assets with determinable lives
|
$
|
9,955
|
|
|
$
|
5,066
|
|
Intangible assets with indefinite lives
|
26,850
|
|
|
—
|
|
||
Total identifiable intangible assets
|
$
|
36,805
|
|
|
$
|
5,066
|
|
|
Three Months Ended March 31
|
|
Nine Months Ended March 31
|
||||||||||||
|
2013
|
|
2012
|
|
2013
|
|
2012
|
||||||||
Share-Based Compensation
|
|
|
|
|
|
|
|
||||||||
Stock options
|
$
|
66
|
|
|
$
|
86
|
|
|
$
|
183
|
|
|
$
|
224
|
|
Other share-based awards
|
30
|
|
|
23
|
|
|
67
|
|
|
53
|
|
||||
Total share-based compensation
|
$
|
96
|
|
|
$
|
109
|
|
|
$
|
250
|
|
|
$
|
277
|
|
|
Pension Benefits
|
|
Other Retiree Benefits
|
||||||||||||
|
Three Months Ended March 31
|
|
Three Months Ended March 31
|
||||||||||||
Amounts in millions
|
2013
|
|
2012
|
|
2013
|
|
2012
|
||||||||
Service cost
|
$
|
76
|
|
|
$
|
62
|
|
|
$
|
48
|
|
|
$
|
35
|
|
Interest cost
|
140
|
|
|
149
|
|
|
65
|
|
|
69
|
|
||||
Expected return on plan assets
|
(146
|
)
|
|
(140
|
)
|
|
(95
|
)
|
|
(109
|
)
|
||||
Amortization of deferred amounts
|
4
|
|
|
6
|
|
|
(5
|
)
|
|
(5
|
)
|
||||
Recognized net actuarial loss
|
55
|
|
|
25
|
|
|
49
|
|
|
25
|
|
||||
Settlement loss
|
2
|
|
|
—
|
|
|
—
|
|
|
—
|
|
||||
Gross benefit cost
|
131
|
|
|
102
|
|
|
62
|
|
|
15
|
|
||||
Dividends on ESOP preferred stock
|
—
|
|
|
—
|
|
|
(17
|
)
|
|
(19
|
)
|
||||
Net periodic benefit cost (credit)
|
$
|
131
|
|
|
$
|
102
|
|
|
$
|
45
|
|
|
$
|
(4
|
)
|
|
Pension Benefits
|
|
Other Retiree Benefits
|
||||||||||||
|
Nine Months Ended
March 31 |
|
Nine Months Ended
March 31 |
||||||||||||
Amounts in millions
|
2013
|
|
2012
|
|
2013
|
|
2012
|
||||||||
Service cost
|
$
|
226
|
|
|
$
|
192
|
|
|
$
|
143
|
|
|
$
|
106
|
|
Interest cost
|
421
|
|
|
458
|
|
|
195
|
|
|
207
|
|
||||
Expected return on plan assets
|
(442
|
)
|
|
(428
|
)
|
|
(286
|
)
|
|
(325
|
)
|
||||
Amortization of deferred amounts
|
13
|
|
|
17
|
|
|
(15
|
)
|
|
(15
|
)
|
||||
Recognized net actuarial loss
|
161
|
|
|
77
|
|
|
149
|
|
|
74
|
|
||||
Curtailment loss
|
2
|
|
|
—
|
|
|
—
|
|
|
—
|
|
||||
Settlement loss
|
2
|
|
|
—
|
|
|
—
|
|
|
—
|
|
||||
Gross benefit cost
|
383
|
|
|
316
|
|
|
186
|
|
|
47
|
|
||||
Dividends on ESOP preferred stock
|
—
|
|
|
—
|
|
|
(52
|
)
|
|
(56
|
)
|
||||
Net periodic benefit cost (credit)
|
$
|
383
|
|
|
$
|
316
|
|
|
$
|
134
|
|
|
$
|
(9
|
)
|
|
Level 1
|
|
Level 2
|
|
Level 3
|
|
Total
|
||||||||||||||||||||||||
Amounts in millions
|
March 31, 2013
|
|
June 30, 2012
|
|
March 31, 2013
|
|
June 30, 2012
|
|
March 31, 2013
|
|
June 30, 2012
|
|
March 31, 2013
|
|
June 30, 2012
|
||||||||||||||||
Assets recorded at fair value:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||||||
Investments:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||||||
U.S. government securities
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
1,509
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
1,509
|
|
|
$
|
—
|
|
Other investments
|
14
|
|
|
9
|
|
|
—
|
|
|
—
|
|
|
25
|
|
|
24
|
|
|
39
|
|
|
33
|
|
||||||||
Derivatives relating to:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||||||
Foreign currency hedges
|
—
|
|
|
—
|
|
|
140
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
140
|
|
|
—
|
|
||||||||
Other foreign currency instruments
(1)
|
—
|
|
|
—
|
|
|
35
|
|
|
86
|
|
|
—
|
|
|
—
|
|
|
35
|
|
|
86
|
|
||||||||
Interest rates
|
—
|
|
|
—
|
|
|
260
|
|
|
298
|
|
|
—
|
|
|
—
|
|
|
260
|
|
|
298
|
|
||||||||
Net investment hedges
|
—
|
|
|
—
|
|
|
251
|
|
|
32
|
|
|
—
|
|
|
—
|
|
|
251
|
|
|
32
|
|
||||||||
Commodities
|
—
|
|
|
—
|
|
|
—
|
|
|
3
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
3
|
|
||||||||
Total assets recorded at fair value
(2)
|
14
|
|
|
9
|
|
|
2,195
|
|
|
419
|
|
|
25
|
|
|
24
|
|
|
2,234
|
|
|
452
|
|
||||||||
Liabilities recorded at fair value:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||||||
Derivatives relating to:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||||||
Foreign currency hedges
|
—
|
|
|
—
|
|
|
—
|
|
|
142
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
142
|
|
||||||||
Other foreign currency instruments
(1)
|
—
|
|
|
—
|
|
|
90
|
|
|
23
|
|
|
—
|
|
|
—
|
|
|
90
|
|
|
23
|
|
||||||||
Net investment hedges
|
—
|
|
|
—
|
|
|
—
|
|
|
19
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
19
|
|
||||||||
Commodities
|
—
|
|
|
—
|
|
|
1
|
|
|
2
|
|
|
—
|
|
|
—
|
|
|
1
|
|
|
2
|
|
||||||||
Liabilities recorded at fair value
(3)
|
—
|
|
|
—
|
|
|
91
|
|
|
186
|
|
|
—
|
|
|
—
|
|
|
91
|
|
|
186
|
|
||||||||
Liabilities not recorded at fair value:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||||||
Long-term debt instruments
(4)
|
23,246
|
|
|
25,829
|
|
|
3,045
|
|
|
2,119
|
|
|
—
|
|
|
—
|
|
|
26,291
|
|
|
27,948
|
|
||||||||
Total liabilities recorded and not recorded at fair value
|
$
|
23,246
|
|
|
$
|
25,829
|
|
|
$
|
3,136
|
|
|
$
|
2,305
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
26,382
|
|
|
$
|
28,134
|
|
(1)
|
Other foreign currency instruments are comprised of foreign currency financial instruments that do not qualify as hedges.
|
(2)
|
Investment securities and all derivative assets are presented in prepaid expenses and other current assets and other noncurrent assets. The amortized cost of the U.S. government securities was
$1,504
and
$0
as of March 31, 2013 and June 30, 2012, respectively. All U.S. government securities have contractual maturities between one and five years.
|
(3)
|
All liabilities are presented in accrued and other liabilities or other noncurrent liabilities.
|
(4)
|
Long-term debt includes the current portion (
$2,513
and
$4,095
as of March 31, 2013 and June 30, 2012, respectively) of debt instruments. Long term debt is not recorded at fair value on a recurring basis, but is measured at fair value for disclosure purposes. Fair values are generally estimated based on quoted market prices for identical or similar instruments.
|
|
Notional Amount
|
|
Fair Value Asset (Liability)
|
||||||||||||
Amounts in Millions
|
March 31, 2013
|
|
June 30, 2012
|
|
March 31, 2013
|
|
June 30, 2012
|
||||||||
Derivatives in Cash Flow Hedging Relationships
|
|
|
|
|
|
|
|
||||||||
Interest rate contracts
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
—
|
|
Foreign currency contracts
|
951
|
|
|
831
|
|
|
140
|
|
|
(142
|
)
|
||||
Total
|
951
|
|
|
831
|
|
|
140
|
|
|
(142
|
)
|
||||
Derivatives in Fair Value Hedging Relationships
|
|
|
|
|
|
|
|
||||||||
Interest rate contracts
|
9,057
|
|
|
10,747
|
|
|
260
|
|
|
298
|
|
||||
Derivatives in Net Investment Hedging Relationships
|
|
|
|
|
|
|
|
||||||||
Net investment hedges
|
1,688
|
|
|
1,768
|
|
|
251
|
|
|
13
|
|
||||
Derivatives Not Designated as Hedging Instruments
|
|
|
|
|
|
|
|
||||||||
Foreign currency contracts
|
9,204
|
|
|
13,210
|
|
|
(55
|
)
|
|
63
|
|
||||
Commodity contracts
|
24
|
|
|
125
|
|
|
(1
|
)
|
|
1
|
|
||||
Total
|
$
|
9,228
|
|
|
$
|
13,335
|
|
|
$
|
(56
|
)
|
|
$
|
64
|
|
|
Amount of Gain (Loss) Recognized in Accumulated OCI on Derivatives (Effective Portion)
|
||||||
Amounts in Millions
|
March 31, 2013
|
|
June 30, 2012
|
||||
Derivatives in Cash Flow Hedging Relationships
|
|
|
|
||||
Interest rate contracts
|
$
|
8
|
|
|
$
|
11
|
|
Foreign currency contracts
|
26
|
|
|
22
|
|
||
Total
|
$
|
34
|
|
|
$
|
33
|
|
Derivatives in Net Investment Hedging Relationships
|
|
|
|
||||
Net investment hedges
|
$
|
156
|
|
|
$
|
6
|
|
|
Amount of Gain (Loss) Reclassified from Accumulated OCI into Income
(1)
|
||||||||||||||
|
Three Months Ended March 31
|
|
Nine Months Ended March 31
|
||||||||||||
Amounts in Millions
|
2013
|
|
2012
|
|
2013
|
|
2012
|
||||||||
Derivatives in Cash Flow Hedging Relationships
|
|
|
|
|
|
|
|
||||||||
Interest rate contracts
|
$
|
2
|
|
|
$
|
2
|
|
|
$
|
5
|
|
|
$
|
5
|
|
Foreign currency contracts
|
82
|
|
|
60
|
|
|
170
|
|
|
33
|
|
||||
Commodity contracts
|
—
|
|
|
2
|
|
|
—
|
|
|
3
|
|
||||
Total
|
$
|
84
|
|
|
$
|
64
|
|
|
$
|
175
|
|
|
$
|
41
|
|
|
|
|
|
|
|
|
|
||||||||
|
Amount of Gain (Loss) Recognized in Income
|
||||||||||||||
|
Three Months Ended March 31
|
|
Nine Months Ended March 31
|
||||||||||||
Amounts in Millions
|
2013
|
|
2012
|
|
2013
|
|
2012
|
||||||||
Derivatives in Fair Value Hedging Relationships
(2)
|
|
|
|
|
|
|
|
||||||||
Interest rate contracts
|
$
|
(64
|
)
|
|
$
|
(19
|
)
|
|
$
|
(39
|
)
|
|
$
|
93
|
|
Debt
|
64
|
|
|
17
|
|
|
43
|
|
|
(97
|
)
|
||||
Total
|
—
|
|
|
(2
|
)
|
|
4
|
|
`
|
(4
|
)
|
||||
Derivatives in Net Investment Hedging Relationships
(2)
|
|
|
|
|
|
|
|
||||||||
Net investment hedges
|
—
|
|
|
9
|
|
|
(1
|
)
|
|
1
|
|
||||
Derivatives Not Designated as Hedging Instruments
(3)
|
|
|
|
|
|
|
|
||||||||
Foreign currency contracts
(4)
|
(209
|
)
|
|
168
|
|
|
17
|
|
|
(823
|
)
|
||||
Commodity contracts
|
—
|
|
|
2
|
|
|
—
|
|
|
1
|
|
||||
Total
|
$
|
(209
|
)
|
|
$
|
170
|
|
|
$
|
17
|
|
|
$
|
(822
|
)
|
(1)
|
The gain or loss on the effective portion of cash flow hedging relationships is reclassified from accumulated OCI into net income in the same period during which the related item affects earnings. Such amounts are included in the Consolidated Statements of Earnings as follows: interest rate contracts in interest expense, foreign currency contracts in selling, general and administrative expense and interest expense and commodity contracts in cost of products sold.
|
(2)
|
The gain or loss on the ineffective portion of interest rate contracts and net investment hedges, if any, is included in the Consolidated Statements of Earnings in interest expense.
|
(3)
|
The gain or loss on contracts not designated as hedging instruments is included in the Consolidated Statements of Earnings as follows: foreign currency contracts in selling, general and administrative expense and commodity contracts in cost of products sold.
|
(4)
|
The gain or loss on non-qualifying foreign currency contracts substantially offsets the foreign currency mark-to-market impact of the related exposure.
|
Amounts in millions
|
|
|
|
|
|
|||||||||||
Changes in Accumulated Other Comprehensive Income / (Loss) by Component
(1)
|
||||||||||||||||
|
Hedges
|
Investment Securities
|
Defined Benefit Retirement Plans
|
Financial Statement Translation
|
Total
|
|||||||||||
Balance at June 30, 2012
|
$
|
(3,673
|
)
|
$
|
(3
|
)
|
$
|
(5,300
|
)
|
$
|
(357
|
)
|
$
|
(9,333
|
)
|
|
OCI before reclassifications
(2)
|
385
|
|
9
|
|
16
|
|
604
|
|
1,014
|
|
||||||
Amounts reclassified out of AOCI
|
(173
|
)
|
—
|
|
210
|
|
—
|
|
37
|
|
||||||
Net current-period OCI
|
212
|
|
9
|
|
226
|
|
604
|
|
1,051
|
|
||||||
Balance at March 31, 2013
|
$
|
(3,461
|
)
|
$
|
6
|
|
$
|
(5,074
|
)
|
$
|
247
|
|
$
|
(8,282
|
)
|
Amounts in millions
|
|
|
||||
Reclassifications out of Accumulated Other Comprehensive Income
|
||||||
|
Three Months Ended March 31
|
Nine Months Ended March 31
|
||||
|
2013
|
2013
|
||||
Gains and (losses) on hedges
|
|
|
||||
Interest rate contracts
(3)
|
$
|
2
|
|
$
|
5
|
|
Foreign exchange contracts
(4)
|
82
|
|
170
|
|
||
Total before tax
|
84
|
|
175
|
|
||
Tax (expense) / benefit
|
(1
|
)
|
(2
|
)
|
||
Net of tax
|
83
|
|
173
|
|
||
|
|
|
||||
Defined benefit retirement plan items
|
|
|
||||
Amortization of deferred amounts
(5)
|
1
|
|
2
|
|
||
Recognized net actuarial gains/(losses)
(5)
|
(104
|
)
|
(310
|
)
|
||
Curtailments and settlements
(5)
|
(2
|
)
|
(4
|
)
|
||
Total before tax
|
(105
|
)
|
(312
|
)
|
||
Tax (expense) / benefit
|
31
|
|
102
|
|
||
Net of tax
|
(74
|
)
|
(210
|
)
|
||
Total reclassifications, net of tax
|
$
|
9
|
|
$
|
(37
|
)
|
|
|
|
|
|
|
|
For the Nine Months Ended March 31, 2013
|
|
|
||||||||||||||
Amounts in millions
|
Accrual Balance June 30, 2012
|
|
|
Charges Previously Reported (Six Months Ended December 31, 2012)
|
Charges for the Three Months Ended
March 31, 2013
|
|
Cash Spent
|
|
Charges Against Assets
|
|
Accrual Balance March 31, 2013
|
||||||||||||
Separations
|
$
|
316
|
|
|
|
$
|
423
|
|
$
|
100
|
|
|
$
|
519
|
|
|
$
|
—
|
|
|
$
|
320
|
|
Asset-Related Costs
|
—
|
|
|
|
42
|
|
28
|
|
|
|
|
|
70
|
|
|
—
|
|
||||||
Other Costs
|
27
|
|
|
|
127
|
|
52
|
|
|
190
|
|
|
|
|
|
16
|
|
||||||
Total
|
$
|
343
|
|
|
|
$
|
592
|
|
$
|
180
|
|
|
$
|
709
|
|
|
$
|
70
|
|
|
$
|
336
|
|
Amounts in millions
|
Three Months Ended March 31
|
|
Nine Months Ended March 31
|
||||
Beauty
|
$
|
17
|
|
|
$
|
106
|
|
Grooming
|
10
|
|
|
46
|
|
||
Health Care
|
27
|
|
|
45
|
|
||
Fabric & Home Care
|
30
|
|
|
100
|
|
||
Baby Care and Family Care
|
22
|
|
|
65
|
|
||
Corporate
(1)
|
74
|
|
|
410
|
|
||
Total Company
|
$
|
180
|
|
|
$
|
772
|
|
|
Three Months Ended March 31
|
|
Nine Months Ended March 31
|
||||||||||||
Amounts in millions
|
2013
|
|
2012
|
|
2013
|
|
2012
|
||||||||
Net sales
|
$
|
—
|
|
|
$
|
350
|
|
|
$
|
—
|
|
|
$
|
1,128
|
|
Earnings from discontinued operations before income taxes
|
—
|
|
|
56
|
|
|
—
|
|
|
199
|
|
||||
Income tax expense
|
—
|
|
|
22
|
|
|
—
|
|
|
66
|
|
||||
Net earnings from discontinued operations
|
$
|
—
|
|
|
$
|
34
|
|
|
$
|
—
|
|
|
$
|
133
|
|
•
|
Overview
|
•
|
Summary of Results
|
•
|
Economic Conditions, Challenges and Risks
|
•
|
Results of Operations – Three and
Nine
Months Ended
March 31, 2013
|
•
|
Business Segment Discussion – Three and
Nine
Months Ended
March 31, 2013
|
•
|
Financial Condition
|
•
|
Reconciliation of Non-GAAP Measures
|
Reportable Segment
|
Categories
|
Billion Dollar Brands
|
Beauty
|
Antiperspirant and Deodorant, Cosmetics, Hair Care, Hair Color, Hair Styling, Personal Cleansing, Prestige Products, Salon Professional, Skin Care
|
Head & Shoulders, Olay, Pantene, SK-II, Wella
|
Grooming
|
Blades and Razors, Electronic Hair Removal Devices, Pre and Post Shave products
|
Braun, Fusion, Gillette, Mach3
|
Health Care
|
Feminine Care, Gastrointestinal, Incontinence, Rapid Diagnostics, Respiratory, Toothbrush, Toothpaste, Other Oral Care, Other Personal Health Care, Vitamins/Minerals/Supplements
|
Always, Crest, Oral-B, Vicks
|
Fabric Care and Home Care
|
Air Care, Bleach and Laundry Additives, Batteries, Dish Care, Fabric Enhancers, Laundry Detergents, Pet Care, Professional, Surface Care
|
Ace, Ariel, Dawn, Downy, Duracell, Febreze, Gain, Iams, Tide
|
Baby Care and Family Care
|
Baby Wipes, Diapers and Pants, Paper Towels, Tissues, Toilet Paper
|
Bounty, Charmin, Pampers
|
|
Three Months Ended March 31
|
||
|
Net Sales
|
|
Net Earnings
|
Beauty
|
23%
|
|
19%
|
Grooming
|
9%
|
|
16%
|
Health Care
|
16%
|
|
18%
|
Fabric Care and Home Care
|
32%
|
|
25%
|
Baby Care and Family Care
|
20%
|
|
22%
|
Total
|
100%
|
|
100%
|
|
Nine Months Ended March 31
|
||
|
Net Sales
|
|
Net Earnings
|
Beauty
|
24%
|
|
22%
|
Grooming
|
9%
|
|
16%
|
Health Care
|
15%
|
|
16%
|
Fabric Care and Home Care
|
32%
|
|
27%
|
Baby Care and Family Care
|
20%
|
|
19%
|
Total
|
100%
|
|
100%
|
•
|
Net sales were consistent with the prior year at $63.5 billion. Organic sales, which exclude the impacts of acquisitions, divestitures and foreign exchange, were up 2%.
|
•
|
Unit volume increased 1%. Volume grew low single digits for Baby Care and Family Care, Fabric Care and Home Care, and Health Care, and declined low single digits for Beauty and Grooming.
|
•
|
Net earnings attributable to Procter & Gamble were $9.4 billion, an increase of $2.3 billion, or 32% versus the prior year period. This net earnings balance increased $1.8 billion or 25% due to non-core items, primarily including a $623 million after tax current period holding gain resulting from P&G's purchase of the balance of its Baby Care and Feminine Care joint venture in Iberia and a prior year $1.5 billion after tax non-cash goodwill and intangible assets impairment charge
|
•
|
Diluted net earnings per share from continuing operations increased 36% to $3.22. Diluted net earnings per share increased 33% to $3.22. The prior year net earnings per share included $0.05 per share from discontinued operations related to our divested Snacks business.
|
•
|
Core net earnings per share increased 8% to $3.27.
|
•
|
Operating cash flow for the fiscal year to date increased 13% to $10.5 billion. Free cash flow, which is operating cash flow less capital expenditures, was $8.1 billion. Free cash flow productivity, which is the ratio of free cash flow to net earnings, was 85%.
|
|
Three Months Ended March 31
|
|||||||||
|
2013
|
|
2012
|
|
% CHG
|
|||||
NET SALES
|
$
|
20,598
|
|
|
$
|
20,194
|
|
|
2
|
%
|
COST OF PRODUCTS SOLD
|
10,344
|
|
|
10,237
|
|
|
1
|
%
|
||
GROSS PROFIT
|
10,254
|
|
|
9,957
|
|
|
3
|
%
|
||
SELLING GENERAL & ADMINISTRATIVE EXPENSE
|
6,849
|
|
|
6,636
|
|
|
3
|
%
|
||
GOODWILL AND INTANGIBLES IMPAIRMENT CHARGES
|
—
|
|
|
22
|
|
|
(100
|
)%
|
||
OPERATING INCOME
|
3,405
|
|
|
3,299
|
|
|
3
|
%
|
||
TOTAL INTEREST EXPENSE
|
163
|
|
|
179
|
|
|
(9
|
)%
|
||
OTHER NON-OPERATING INCOME/(EXPENSE), NET
|
46
|
|
|
67
|
|
|
(31
|
)%
|
||
EARNINGS FROM CONTINUING OPERATIONS BEFORE INCOME TAXES
|
3,288
|
|
|
3,187
|
|
|
3
|
%
|
||
INCOME TAXES ON CONTINUING OPERATIONS
|
697
|
|
|
754
|
|
|
(8
|
)%
|
||
NET EARNINGS FROM CONTINUING OPERATIONS
|
2,591
|
|
|
2,433
|
|
|
6
|
%
|
||
NET EARNINGS FROM DISCONTINUED OPERATIONS
|
—
|
|
|
34
|
|
|
(100
|
)%
|
||
NET EARNINGS
|
2,591
|
|
|
2,467
|
|
|
5
|
%
|
||
LESS: NET EARNINGS ATTRIBUTABLE TO NONCONTROLLING INTERESTS
|
25
|
|
|
56
|
|
|
(55
|
)%
|
||
NET EARNINGS ATTRIBUTABLE TO PROCTER & GAMBLE
|
$
|
2,566
|
|
|
$
|
2,411
|
|
|
6
|
%
|
EFFECTIVE TAX RATE ON CONTINUING OPERATIONS
|
21.2
|
%
|
|
23.7
|
%
|
|
|
|||
|
|
|
|
|
|
|||||
BASIC NET EARNINGS PER COMMON SHARE (1):
|
|
|
|
|
|
|||||
EARNINGS FROM CONTINUING OPERATIONS
|
$
|
0.92
|
|
|
$
|
0.84
|
|
|
10
|
%
|
EARNINGS FROM DISCONTINUED OPERATIONS
|
—
|
|
|
0.01
|
|
|
(100
|
)%
|
||
BASIC NET EARNINGS PER COMMON SHARE
|
0.92
|
|
|
0.85
|
|
|
8
|
%
|
||
DILUTED NET EARNINGS PER COMMON SHARE (1):
|
|
|
|
|
|
|||||
EARNINGS FROM CONTINUING OPERATIONS
|
$
|
0.88
|
|
|
$
|
0.81
|
|
|
9
|
%
|
EARNINGS FROM DISCONTINUED OPERATIONS
|
—
|
|
|
0.01
|
|
|
(100
|
)%
|
||
DILUTED NET EARNINGS PER COMMON SHARE
|
$
|
0.88
|
|
|
$
|
0.82
|
|
|
7
|
%
|
DIVIDENDS PER COMMON SHARE
|
$
|
0.562
|
|
|
$
|
0.525
|
|
|
7
|
%
|
AVERAGE DILUTED SHARES OUTSTANDING
|
2,930.7
|
|
|
2,937.8
|
|
|
|
|||
(1)
Basic net earnings per share and diluted net earnings per share are calculated on net earnings attributable to Procter & Gamble
|
||||||||||
|
|
|
|
|
|
|||||
COMPARISONS AS A % OF NET SALES
|
|
|
|
|
Basis Pt Chg
|
|||||
GROSS MARGIN
|
49.8
|
%
|
|
49.3
|
%
|
|
50
|
|
||
SELLING, GENERAL & ADMINISTRATIVE EXPENSE
|
33.3
|
%
|
|
32.9
|
%
|
|
40
|
|
||
OPERATING MARGIN
|
16.5
|
%
|
|
16.3
|
%
|
|
20
|
|
||
EARNINGS FROM CONTINUING OPERATIONS BEFORE INCOME TAXES
|
16.0
|
%
|
|
15.8
|
%
|
|
20
|
|
||
NET EARNINGS ATTRIBUTABLE TO PROCTER & GAMBLE
|
12.5
|
%
|
|
11.9
|
%
|
|
60
|
|
|
Net Sales Change Drivers 2013 vs. 2012 (Three Months Ended March 31)
|
|||||||||||||||||||
|
Volume with
Acquisitions
& Divestitures
|
|
Volume
Excluding
Acquisitions
& Divestitures
|
|
Foreign
Exchange
|
|
Price
|
|
Mix
|
|
Other*
|
|
Net Sales
Growth
|
|||||||
Beauty
|
-1
|
%
|
|
-1
|
%
|
|
-1
|
%
|
|
1
|
%
|
|
-1
|
%
|
|
0
|
%
|
|
-2
|
%
|
Grooming
|
-2
|
%
|
|
0
|
%
|
|
-1
|
%
|
|
3
|
%
|
|
-1
|
%
|
|
-1
|
%
|
|
-2
|
%
|
Health Care
|
5
|
%
|
|
5
|
%
|
|
-1
|
%
|
|
1
|
%
|
|
2
|
%
|
|
1
|
%
|
|
8
|
%
|
Fabric Care and Home Care
|
3
|
%
|
|
3
|
%
|
|
-1
|
%
|
|
0
|
%
|
|
-2
|
%
|
|
0
|
%
|
|
0
|
%
|
Baby Care and Family Care
|
2
|
%
|
|
2
|
%
|
|
-1
|
%
|
|
2
|
%
|
|
0
|
%
|
|
0
|
%
|
|
3
|
%
|
TOTAL COMPANY
|
2
|
%
|
|
2
|
%
|
|
-1
|
%
|
|
1
|
%
|
|
0
|
%
|
|
0
|
%
|
|
2
|
%
|
|
Nine Months Ended March 31
|
|||||||||
|
2013
|
|
2012
|
|
% CHG
|
|||||
NET SALES
|
$
|
63,512
|
|
|
$
|
63,468
|
|
|
—
|
%
|
COST OF PRODUCTS SOLD
|
31,574
|
|
|
31,894
|
|
|
(1
|
)%
|
||
GROSS PROFIT
|
31,938
|
|
|
31,574
|
|
|
1
|
%
|
||
SELLING GENERAL & ADMINISTRATIVE EXPENSE
|
20,090
|
|
|
19,769
|
|
|
2
|
%
|
||
GOODWILL AND INTANGIBLES IMPAIRMENT CHARGES
|
—
|
|
|
1,576
|
|
|
(100
|
)%
|
||
OPERATING INCOME
|
11,848
|
|
|
10,229
|
|
|
16
|
%
|
||
TOTAL INTEREST EXPENSE
|
504
|
|
|
587
|
|
|
(14
|
)%
|
||
OTHER NON-OPERATING INCOME/(EXPENSE), NET
|
988
|
|
|
238
|
|
|
315
|
%
|
||
EARNINGS FROM CONTINUING OPERATIONS BEFORE INCOME TAXES
|
12,332
|
|
|
9,880
|
|
|
25
|
%
|
||
INCOME TAXES ON CONTINUING OPERATIONS
|
2,812
|
|
|
2,776
|
|
|
1
|
%
|
||
NET EARNINGS FROM CONTINUING OPERATIONS
|
9,520
|
|
|
7,104
|
|
|
34
|
%
|
||
NET EARNINGS FROM DISCONTINUED OPERATIONS
|
—
|
|
|
133
|
|
|
(100
|
)%
|
||
NET EARNINGS
|
9,520
|
|
|
7,237
|
|
|
32
|
%
|
||
LESS: NET EARNINGS ATTRIBUTABLE TO NONCONTROLLING INTERESTS
|
83
|
|
|
112
|
|
|
(26
|
)%
|
||
NET EARNINGS ATTRIBUTABLE TO PROCTER & GAMBLE
|
$
|
9,437
|
|
|
$
|
7,125
|
|
|
32
|
%
|
EFFECTIVE TAX RATE ON CONTINUING OPERATIONS
|
22.8
|
%
|
|
28.1
|
%
|
|
|
|||
|
|
|
|
|
|
|||||
BASIC NET EARNINGS PER COMMON SHARE (1):
|
|
|
|
|
|
|||||
EARNINGS FROM CONTINUING OPERATIONS
|
$
|
3.38
|
|
|
$
|
2.47
|
|
|
37
|
%
|
EARNINGS FROM DISCONTINUED OPERATIONS
|
—
|
|
|
0.05
|
|
|
(100
|
)%
|
||
BASIC NET EARNINGS PER COMMON SHARE
|
3.38
|
|
|
2.52
|
|
|
34
|
%
|
||
DILUTED NET EARNINGS PER COMMON SHARE (1):
|
|
|
|
|
|
|||||
EARNINGS FROM CONTINUING OPERATIONS
|
$
|
3.22
|
|
|
$
|
2.37
|
|
|
36
|
%
|
EARNINGS FROM DISCONTINUED OPERATIONS
|
—
|
|
|
0.05
|
|
|
(100
|
)%
|
||
DILUTED NET EARNINGS PER COMMON SHARE
|
3.22
|
|
|
2.42
|
|
|
33
|
%
|
||
DIVIDENDS PER COMMON SHARE
|
$
|
1.686
|
|
|
$
|
1.575
|
|
|
7
|
%
|
AVERAGE DILUTED SHARES OUTSTANDING
|
2,927.6
|
|
|
2,944.9
|
|
|
|
|||
(1)
Basic net earnings per share and diluted net earnings per share are calculated on net earnings attributable to Procter & Gamble
|
||||||||||
|
|
|
|
|
|
|||||
COMPARISONS AS A % OF NET SALES
|
|
|
|
|
Basis Pt Chg
|
|||||
GROSS MARGIN
|
50.3
|
%
|
|
49.7
|
%
|
|
60
|
|
||
SELLING, GENERAL & ADMINISTRATIVE EXPENSE
|
31.6
|
%
|
|
31.1
|
%
|
|
50
|
|
||
OPERATING MARGIN
|
18.7
|
%
|
|
16.1
|
%
|
|
260
|
|
||
EARNINGS FROM CONTINUING OPERATIONS BEFORE INCOME TAXES
|
19.4
|
%
|
|
15.6
|
%
|
|
380
|
|
||
NET EARNINGS ATTRIBUTABLE TO PROCTER & GAMBLE
|
14.9
|
%
|
|
11.2
|
%
|
|
370
|
|
|
Net Sales Change Drivers 2013 vs. 2012 (Nine Months Ended March 31)
|
|||||||||||||||||||
|
Volume with
Acquisitions
& Divestitures
|
|
Volume
Excluding
Acquisitions
& Divestitures
|
|
Foreign
Exchange
|
|
Price
|
|
Mix
|
|
Other*
|
|
Net Sales
Growth
|
|||||||
Beauty
|
-2
|
%
|
|
-1
|
%
|
|
-2
|
%
|
|
2
|
%
|
|
-1
|
%
|
|
0
|
%
|
|
-3
|
%
|
Grooming
|
-2
|
%
|
|
0
|
%
|
|
-4
|
%
|
|
2
|
%
|
|
0
|
%
|
|
0
|
%
|
|
-4
|
%
|
Health Care
|
3
|
%
|
|
2
|
%
|
|
-3
|
%
|
|
2
|
%
|
|
1
|
%
|
|
-1
|
%
|
|
2
|
%
|
Fabric Care and Home Care
|
2
|
%
|
|
2
|
%
|
|
-2
|
%
|
|
1
|
%
|
|
-1
|
%
|
|
0
|
%
|
|
0
|
%
|
Baby Care and Family Care
|
3
|
%
|
|
3
|
%
|
|
-2
|
%
|
|
2
|
%
|
|
-1
|
%
|
|
0
|
%
|
|
2
|
%
|
TOTAL COMPANY
|
1
|
%
|
|
1
|
%
|
|
-2
|
%
|
|
2
|
%
|
|
-1
|
%
|
|
0
|
%
|
|
0
|
%
|
|
Three Months Ended March 31, 2013
|
|||||||||||||||||
|
Net Sales
|
|
% Change Versus Year Ago
|
|
Earnings from Continuing Operations Before Income Taxes
|
|
% Change Versus Year Ago
|
|
Net Earnings from Continuing Operations
|
|
% Change Versus Year Ago
|
|||||||
Beauty
|
$
|
4,763
|
|
|
(2
|
)%
|
|
692
|
|
|
(3
|
)%
|
|
535
|
|
|
2
|
%
|
Grooming
|
1,931
|
|
|
(2
|
)%
|
|
593
|
|
|
12
|
%
|
|
444
|
|
|
12
|
%
|
|
Health Care
|
3,274
|
|
|
8
|
%
|
|
731
|
|
|
15
|
%
|
|
493
|
|
|
20
|
%
|
|
Fabric Care and Home Care
|
6,587
|
|
|
—
|
%
|
|
1,087
|
|
|
(6
|
)%
|
|
693
|
|
|
(3
|
)%
|
|
Baby Care and Family Care
|
4,277
|
|
|
3
|
%
|
|
939
|
|
|
4
|
%
|
|
608
|
|
|
6
|
%
|
|
Corporate
|
(234
|
)
|
|
N/A
|
|
|
(754
|
)
|
|
N/A
|
|
|
(182
|
)
|
|
N/A
|
|
|
Total Company
|
20,598
|
|
|
2
|
%
|
|
3,288
|
|
|
3
|
%
|
|
2,591
|
|
|
6
|
%
|
|
Nine Months Ended March 31, 2013
|
|||||||||||||||||||
|
Net Sales
|
|
% Change Versus Year Ago
|
|
Earnings from Continuing Operations Before Income Taxes
|
|
% Change Versus Year Ago
|
|
Net Earnings from Continuing Operations
|
|
% Change Versus Year Ago
|
|||||||||
Beauty
|
$
|
15,106
|
|
|
(3
|
)%
|
|
$
|
2,682
|
|
|
1
|
%
|
|
$
|
2,070
|
|
|
3
|
%
|
Grooming
|
6,057
|
|
|
(4
|
)%
|
|
1,922
|
|
|
3
|
%
|
|
1,428
|
|
|
2
|
%
|
|||
Health Care
|
9,714
|
|
|
2
|
%
|
|
2,222
|
|
|
—
|
%
|
|
1,512
|
|
|
1
|
%
|
|||
Fabric Care and Home Care
|
20,711
|
|
|
—
|
%
|
|
3,836
|
|
|
5
|
%
|
|
2,502
|
|
|
10
|
%
|
|||
Baby Care and Family Care
|
12,598
|
|
|
2
|
%
|
|
2,693
|
|
|
7
|
%
|
|
1,731
|
|
|
9
|
%
|
|||
Corporate
|
(674
|
)
|
|
N/A
|
|
|
(1,023
|
)
|
|
N/A
|
|
|
277
|
|
|
N/A
|
|
|||
Total Company
|
63,512
|
|
|
—
|
%
|
|
12,332
|
|
|
25
|
%
|
|
9,520
|
|
|
34
|
%
|
January - March 2013
|
Net Sales Growth
|
|
Foreign Exchange Impact
|
|
Acquisition/ Divestiture Impact*
|
|
Organic Sales Growth
|
||||
Beauty
|
(2
|
)%
|
|
1
|
%
|
|
—
|
%
|
|
(1
|
)%
|
Grooming
|
(2
|
)%
|
|
1
|
%
|
|
3
|
%
|
|
2
|
%
|
Health Care
|
8
|
%
|
|
1
|
%
|
|
(1
|
)%
|
|
8
|
%
|
Fabric Care and Home Care
|
—
|
%
|
|
1
|
%
|
|
—
|
%
|
|
1
|
%
|
Baby Care and Family Care
|
3
|
%
|
|
1
|
%
|
|
—
|
%
|
|
4
|
%
|
Total P&G
|
2
|
%
|
|
1
|
%
|
|
—
|
%
|
|
3
|
%
|
July 2012 - March 2013
|
Net Sales Growth
|
|
Foreign Exchange Impact
|
|
Acquisition/ Divestiture Impact*
|
|
Organic Sales Growth
|
||||
Beauty
|
(3
|
)%
|
|
2
|
%
|
|
1
|
%
|
|
—
|
%
|
Grooming
|
(4
|
)%
|
|
4
|
%
|
|
2
|
%
|
|
2
|
%
|
Health Care
|
2
|
%
|
|
3
|
%
|
|
—
|
%
|
|
5
|
%
|
Fabric Care and Home Care
|
—
|
%
|
|
2
|
%
|
|
—
|
%
|
|
2
|
%
|
Baby Care and Family Care
|
2
|
%
|
|
2
|
%
|
|
—
|
%
|
|
4
|
%
|
Total P&G
|
—
|
%
|
|
2
|
%
|
|
—
|
%
|
|
2
|
%
|
Three Months Ended March 31
|
2013
|
|
2012
|
||||
Diluted Net Earnings Per Share - Continuing Operations
|
$
|
0.88
|
|
|
$
|
0.81
|
|
Venezuela balance sheet devaluation impacts
|
0.08
|
|
|
—
|
|
||
Impairment Charges
|
—
|
|
|
0.01
|
|
||
Incremental Restructuring Charges
|
0.03
|
|
|
0.12
|
|
||
CORE EPS
|
$
|
0.99
|
|
|
$
|
0.94
|
|
Core EPS Growth
|
5
|
%
|
|
|
Nine Months Ended March 31
|
2013
|
|
2012
|
||||
Diluted Net Earnings Per Share - Continuing Operations
|
$
|
3.22
|
|
|
$
|
2.37
|
|
Venezuela balance sheet devaluation impacts
|
0.08
|
|
|
—
|
|
||
Gain on buyout of Iberian JV
|
(0.21
|
)
|
|
—
|
|
||
Impairment Charges
|
—
|
|
|
0.51
|
|
||
Incremental Restructuring Charges
|
0.16
|
|
|
0.12
|
|
||
Charges for Pending European Legal Matters
|
0.01
|
|
|
0.03
|
|
||
Rounding impacts
|
0.01
|
|
|
—
|
|
||
CORE EPS
|
$
|
3.27
|
|
|
$
|
3.03
|
|
Core EPS Growth
|
8
|
%
|
|
|
|
Operating Cash Flow
|
|
Capital Spending
|
|
Free Cash Flow
|
|
Net Earnings
|
|
Free Cash Flow
Productivity |
||||
Jul - Mar '13
|
$
|
10,481
|
|
|
$
|
(2,426
|
)
|
|
8,055
|
|
$9,520
|
|
85%
|
Item 3.
|
Quantitative and Qualitative Disclosures About Market Risk.
|
Item 4.
|
Controls and Procedures.
|
Item 1.
|
Legal Proceedings.
|
Item 1A.
|
Risk Factors.
|
•
|
compliance with U.S. laws affecting operations outside of the United States, such as the Foreign Corrupt Practices Act;
|
•
|
compliance with a variety of local regulations and laws;
|
•
|
changes in tax laws and the interpretation of those laws;
|
•
|
changes in foreign currency exchange controls;
|
•
|
discriminatory or conflicting fiscal policies;
|
•
|
difficulties enforcing intellectual property and contractual rights in certain jurisdictions;
|
•
|
greater risk of uncollectible accounts and longer collection cycles;
|
•
|
effective and immediate implementation of control environment processes across our diverse operations and employee base; and
|
•
|
imposition of more or new tariffs, quotas, trade barriers and similar restrictions on our sales outside the United States.
|
•
|
ordering and managing materials from suppliers;
|
•
|
converting materials to finished products;
|
•
|
shipping product to customers;
|
•
|
marketing and selling products to consumers;
|
•
|
collecting and storing customer, consumer, employee, investor, and other stakeholder information and personal data;
|
•
|
processing transactions;
|
•
|
summarizing and reporting results of operations;
|
•
|
hosting, processing, and sharing confidential and proprietary research, business plans, and financial information;
|
•
|
complying with regulatory, legal or tax requirements;
|
•
|
providing data security; and
|
•
|
handling other processes necessary to manage our business.
|
Item 2.
|
Unregistered Sales of Equity Securities and Use of Proceeds.
|
Period
|
Total Number of Shares Purchased
(1)
|
|
Average Price Paid per Share
(2)
|
|
Total Number of Shares Purchased as Part of Publicly Announced Plans or Programs
(3)
|
|
Approximate Dollar Value of Shares That May Yet Be Purchased Under our Share Repurchase Program ($ in billions)
(3)
|
01/01/2013 - 01/31/2013
|
0
|
|
—
|
|
—
|
|
|
02/01/2013 - 02/28/2013
|
6,284,388
|
|
$76.38
|
|
6,284,388
|
|
See Note 3
|
03/01/2013 - 03/31/2013
|
6,760,980
|
|
$76.91
|
|
6,760,980
|
|
|
(1)
|
The total number of shares purchased was 13,045,368 for the quarter. All transactions were made in the open market with large financial institutions. This table excludes shares withheld from employees to satisfy minimum tax withholding requirements on option exercises and other equity-based transactions. The Company administers cashless exercises through an independent third party and does not repurchase stock in connection with cashless exercises.
|
(2)
|
Average price paid per share is calculated on a settlement basis and excludes commission.
|
(3)
|
On April 24, 2013, the Company stated that fiscal year 2012-13 share repurchases to reduce Company shares outstanding are estimated to be approximately $6 billion, notwithstanding any purchases under the Company's compensation and benefit plans. Purchases may be made in the open market and/or private transactions and purchases may be increased, decreased or discontinued at any time without prior notice. The share repurchases are authorized pursuant to a resolution issued by the Company's Board of Directors and is expected to be financed by issuing a combination of long-term and short-term debt.
|
Item 6.
|
Exhibits
|
3-1
|
|
|
Amended Articles of Incorporation (as amended by shareholders at the annual meeting on October 11, 2011) (Incorporated by reference to Exhibit (3-1) of the Company's Form 10-Q for the quarter ended September 30, 2011)
|
|
|
|
|
3-2
|
|
|
Regulations (as amended by the Board of Directors effective January 16, 2012 pursuant to authority granted by shareholders at the annual meeting on October 13, 2009). (Incorporated by reference to Exhibit (3-2) of the Company's Form 10-Q for the quarter ended December 31, 2011)
|
|
|
|
|
10-1
|
|
|
The Procter & Gamble 2001 Stock and Incentive Compensation Plan (as amended on August 17, 2007), which was originally adopted by shareholders at the annual meeting on October 9, 2001.*
|
|
|
|
|
11
|
|
|
Computation of Earnings per Share
|
|
|
|
|
12
|
|
|
Computation of Ratio of Earnings to Fixed Charges
|
|
|
|
|
31.1
|
|
|
Rule 13a-14(a)/15d-14(a) Certification – Chief Executive Officer
|
|
|
|
|
31.2
|
|
|
Rule 13a-14(a)/15d-14(a) Certification – Chief Financial Officer
|
|
|
|
|
32.1
|
|
|
Section 1350 Certifications – Chief Executive Officer
|
|
|
|
|
32.2
|
|
|
Section 1350 Certifications – Chief Financial Officer
|
|
|
|
|
101.INS
(1)
|
|
|
XBRL Instance Document
|
|
|
|
|
101.SCH
(1)
|
|
|
XBRL Taxonomy Extension Schema Document
|
|
|
|
|
101.CAL
(1)
|
|
|
XBRL Taxonomy Extension Calculation Linkbase Document
|
|
|
|
|
101.DEF
(1)
|
|
|
XBRL Taxonomy Definition Linkbase Document
|
|
|
|
|
101.LAB
(1)
|
|
|
XBRL Taxonomy Extension Label Linkbase Document
|
|
|
|
|
101.PRE
(1)
|
|
|
XBRL Taxonomy Extension Presentation Linkbase Document
|
(1)
|
XBRL (Extensible Business Reporting Language) information is furnished and not filed or a part of a registration statement or prospectus for purposes of sections 11 or 12 of the Securities Act of 1933, is deemed not filed for purposes of section 18 of the Securities Exchange Act of 1934, and otherwise is not subject to liability under these sections.
|
*
|
Compensatory plan or arrangement
|
|
|
|
|
|
|
|
|
|
THE PROCTER & GAMBLE COMPANY
|
|
|
|
||
April 24, 2013
|
|
|
|
/s/ VALARIE L. SHEPPARD
|
Date
|
|
|
|
(Valarie L. Sheppard)
|
|
|
|
|
Senior Vice President and Comptroller
|
|
|
|
|
Exhibit
|
|
|
|
|
|
||
3-1
|
|
|
Amended Articles of Incorporation (as amended by shareholders at the annual meeting on October 11, 2011) (Incorporated by reference to Exhibit (3-1) of the Company's Form 10-Q for the quarter ended September 30, 2011)
|
|
|
|
|
3-2
|
|
|
Regulations (as amended by the Board of Directors effective January 16, 2012 pursuant to authority granted by shareholders at the annual meeting on October 13, 2009). (Incorporated by reference to Exhibit (3-2) of the Company's Form 10-Q for the quarter ended December 31, 2011)
|
|
|
|
|
11
|
|
|
Computation of Earnings per Share
|
|
|
||
10-1
|
|
|
The Procter & Gamble 2001 Stock and Incentive Compensation Plan (as amended on August 17, 2007), which was originally adopted by shareholders at the annual meeting on October 9, 2001.
|
|
|
|
|
12
|
|
|
Computation of Ratio of Earnings to Fixed Charges
|
|
|
||
31.1
|
|
|
Rule 13a-14(a)/15d-14(a) Certification – Chief Executive Officer
|
|
|
||
31.2
|
|
|
Rule 13a-14(a)/15d-14(a) Certification – Chief Financial Officer
|
|
|
||
32.1
|
|
|
Section 1350 Certifications – Chief Executive Officer
|
|
|
||
32.2
|
|
|
Section 1350 Certifications – Chief Financial Officer
|
|
|
||
101.INS
(1)
|
|
|
XBRL Instance Document
|
|
|
||
101.SCH
(1)
|
|
|
XBRL Taxonomy Extension Schema Document
|
|
|
||
101.CAL
(1)
|
|
|
XBRL Taxonomy Extension Calculation Linkbase Document
|
|
|
||
101.DEF
(1)
|
|
|
XBRL Taxonomy Definition Linkbase Document
|
|
|
||
101.LAB
(1)
|
|
|
XBRL Taxonomy Extension Label Linkbase Document
|
|
|
||
101.PRE
(1)
|
|
|
XBRL Taxonomy Extension Presentation Linkbase Document
|
(1)
|
XBRL (Extensible Business Reporting Language) information is furnished and not filed or a part of a registration statement or prospectus for purposes of sections 11 or 12 of the Securities Act of 1933, is deemed not filed for purposes of section 18 of the Securities Exchange Act of 1934, and otherwise is not subject to liability under these sections.
|
No information found
* THE VALUE IS THE MARKET VALUE AS OF THE LAST DAY OF THE QUARTER FOR WHICH THE 13F WAS FILED.
FUND | NUMBER OF SHARES | VALUE ($) | PUT OR CALL |
---|
DIRECTORS | AGE | BIO | OTHER DIRECTOR MEMBERSHIPS |
---|---|---|---|
Rob Krcmarov President and Chief Executive Officer, Director Mr. Krcmarov was appointed our President and Chief Executive Officer in November 2024 and is a member of the Board of Directors. Prior to joining Hecla, he worked in various leadership roles at Barrick Gold Corporation beginning in 2001, including serving on the executive leadership team for 13 years. His most recent role at Barrick was as Executive Vice President – Exploration and Growth from March 2016 to November 2021. Mr. Krcmarov has over three decades of industry experience. He has been a member of the board for Orla Mining Ltd. since November 2023. He also served on the boards of Coeur Mining from December 2023 to September 2024, Osisko Gold Royalties from October 2022 to October 2024, and Major Drilling Group International from September 2022 to October 2024. | |||
Mr. Baker departed the company on May 22, 2024. Ms. Boggs served as our ICEO from May 22, 2024 until November 7, 2024. Mr. Krcmarov became our President and CEO on November 7, 2024. Consequently, the salaries presented for them are prorated. In accordance with SEC rules, the salary presented for Ms. Boggs also includes $180,000 in director fees paid to her for 2024. | |||
Catherine “Cassie” J. Boggs Independent Director Ms. Boggs served as our Interim President and Chief Executive Officer between May 22 and November 7, 2024. Previously she was the General Counsel at Resource Capital Funds from January 2011 until her retirement in February 2019. Since November 2019, she has been serving as an Intermittent Expert in mining with the US Department of Commerce’s Commercial Law Development Program. She was a board member of Funzeleo from January 2016 to September 2021, as well as briefly serving on the board of U.S. Energy Corp. from June 2019 to December 2019. She has served as a board member of Capital Limited since September 2021 and is an Adjunct Professor at the University of Denver, Sturm College of Law. Board Qualification and Skills Ms. Boggs has over 40 years’ experience as an attorney in the mining and natural resources sectors, in both domestic and international mining. She has extensive experience in leadership in the mining industry, having worked for Barrick Gold Corporation, serving in a variety of leadership roles, including serving as the Chief Executive Officer of Tethyan Copper Company, interim President of the African Business Unit, and as interim General Counsel of African Barrick Gold. She also has experience in due diligence, country and political risk assessments, and the structuring and implementation of risk mitigation strategies. Hecla Committees Executive Compensation Governance and Social Responsibility Non-Executive Stock Award |
Name and Principal Position |
Year |
Salary
($) |
Stock
Awards ($) |
Non-Equity
Incentive Plan Compensation ($) |
Change in
Pension Value and Non-Qualified Deferred Compensation Earnings ($) |
All Other
Compensation ($) |
Total
($) |
|||||||||||||||||||||
Rob Krcmarov President and CEO |
2024 | 93,500 | — | 132,458 | — | 462 | 226,420 | |||||||||||||||||||||
Russell D. Lawlar Sr. Vice President – Chief Financial Officer |
2024 | 379,500 | 595,670 | 568,515 | 70,653 | 23,469 | 1,637,807 | |||||||||||||||||||||
2023 | 352,688 | 329,041 | 472,350 | 38,428 | 22,569 | 1,215,076 | ||||||||||||||||||||||
2022 | 294,792 | 306,052 | 674,891 | — | 20,818 | 1,296,553 | ||||||||||||||||||||||
Michael L. Clary Senior Vice President – Chief Administrative Officer |
2024 | 345,000 | 555,646 | 525,777 | 476,587 | 23,469 | 1,926,479 | |||||||||||||||||||||
2023 | 320,625 | 303,738 | 462,000 | 1,353,530 | 22,463 | 2,462,356 | ||||||||||||||||||||||
2022 | 281,042 | 282,509 | 778,688 | — | 20,711 | 1,362,950 | ||||||||||||||||||||||
David C. Sienko Senior Vice President – General Counsel and Secretary |
2024 | 326,875 | 553,002 | 539,924 | 137,319 | 22,339 | 1,579,459 | |||||||||||||||||||||
2023 | 306,875 | 263,057 | 342,000 | — | 22,420 | 934,352 | ||||||||||||||||||||||
2022 | 281,042 | 268,235 | 671,250 | — | 20,711 | 1,241,238 | ||||||||||||||||||||||
Robert D. Brown Vice President – Corporate Development and Sustainability |
2024 | 330,000 | 506,118 | 434,774 | 75,461 | 7,987 | 1,354,340 | |||||||||||||||||||||
2023 | 315,000 | 275,679 | 383,250 | 86,114 | 8,066 | 1,068,109 | ||||||||||||||||||||||
2022 | 282,000 | 268,235 | 761,250 | — | 20,415 | 1,331,900 | ||||||||||||||||||||||
Catherine J. Boggs Former Interim President and CEO, Board Chair |
2024 | 606,735 | 408,603 | — | — | — | 1,015,338 | |||||||||||||||||||||
Phillips S. Baker, Jr. Former President and CEO |
2024 | 358,188 | — | — | 44,250 | 1,764,140 | 2,166,578 | |||||||||||||||||||||
2023 | 784,375 | 1,216,206 | 1,434,375 | 685,029 | 22,568 | 4,142,554 | ||||||||||||||||||||||
2022 | 722,917 | 1,205,255 | 2,630,625 | — | 21,069 | 4,579,866 |
Suppliers
Supplier name | Ticker |
---|---|
3M Company | MMM |
Anheuser-Busch InBev SA/NV | BUD |
Thermo Fisher Scientific Inc. | TMO |
CSX Corporation | CSX |
Illinois Tool Works Inc. | ITW |
Dow Inc. | DOW |
FMC Corporation | FMC |
Price
Yield
Owner | Position | Direct Shares | Indirect Shares |
---|---|---|---|
BAKER PHILLIPS S JR | - | 5,544,500 | 50,515 |
BAKER PHILLIPS S JR | - | 5,417,800 | 50,515 |
Sienko David C | - | 914,571 | 15,285 |
Brown Robert Denis | - | 514,747 | 0 |
Boggs Catherine J | - | 348,169 | 0 |
Krcmarov Robert | - | 346,453 | 0 |
Aguiar Rodriguez Carlos Roberto | - | 197,359 | 5,369 |
Allen Kurt | - | 173,700 | 23,254 |
Johnson George R | - | 25,773 | 0 |
STANLEY CHARLES B | - | 0 | 288,059 |